New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
What is metastatic breast cancer and how is it treated?

What is metastatic breast cancer and how is it treated?

by Maryam B. Lustberg, MD, MPH, Chief Of Breast Medical Oncology, Yale Cancer CenterMetastatic breast cancer can be a daunting diagnosis, but the prognosis has improved somewhat with advances in treat
World medicine December 15,2023
What is metastatic breast cancer and how is it treated?

What is metastatic breast cancer and how is it treated?

by Maryam B. Lustberg, MD, MPH, Chief Of Breast Medical Oncology, Yale Cancer CenterMetastatic breast cancer can be a daunting diagnosis, but the prognosis has improved somewhat with advances in treat
World medicine December 15,2023
Immune cells take cue from animal kingdom: Together, everyone achieves more

Immune cells take cue from animal kingdom: Together, everyone achieves more

byUniversity of Rochester Medical CenterMuch like birds fly in flocks to conserve energy, dolphins swim in pods to mate and find food, and colonies of ants create complex nests to protect their
World medicine December 15,2023
Immune cells take cue from animal kingdom: Together, everyone achieves more

Immune cells take cue from animal kingdom: Together, everyone achieves more

byUniversity of Rochester Medical CenterMuch like birds fly in flocks to conserve energy, dolphins swim in pods to mate and find food, and colonies of ants create complex nests to protect their
World medicine December 15,2023
What is a breast medicine specialist?

What is a breast medicine specialist?

by Sonya Goins, Mayo Clinic News NetworkCredit: Unsplash/CC0 Public DomainMany people think that a breast health specialist only treats cancer, but the truth is that these doctors handle a wide range
World medicine December 15,2023
What is a breast medicine specialist?

What is a breast medicine specialist?

by Sonya Goins, Mayo Clinic News NetworkCredit: Unsplash/CC0 Public DomainMany people think that a breast health specialist only treats cancer, but the truth is that these doctors handle a wide range
World medicine December 15,2023
Deep learning reveals valuable clues about kidney cancer in pathology slides

Deep learning reveals valuable clues about kidney cancer in pathology slides

byDana-Farber Cancer InstituteCredit: Pixabay/CC0 Public DomainA team of Dana-Farber researchers has identified a potential new way to assess clinically valuable features of clear cell renal cel
World medicine December 15,2023
Deep learning reveals valuable clues about kidney cancer in pathology slides

Deep learning reveals valuable clues about kidney cancer in pathology slides

byDana-Farber Cancer InstituteCredit: Pixabay/CC0 Public DomainA team of Dana-Farber researchers has identified a potential new way to assess clinically valuable features of clear cell renal cel
World medicine December 15,2023
Editorial: Cancer drug development yesterday, today and tomorrow

Editorial: Cancer drug development yesterday, today and tomorrow

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainA new editorial paper was published inOncoscience, titled "Cancer drug development yesterday, today and tomorrow."In this new edi
World medicine December 15,2023
Editorial: Cancer drug development yesterday, today and tomorrow

Editorial: Cancer drug development yesterday, today and tomorrow

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainA new editorial paper was published inOncoscience, titled "Cancer drug development yesterday, today and tomorrow."In this new edi
World medicine December 15,2023
How social media can help to understand treatment experiences of survivors of rare cancers

How social media can help to understand treatment experiences of survivors of rare cancers

byHudson Institute of Medical ResearchL–R: Associate Professor Simon Chu and Maria Alexiadis. Credit: Hudson Institute of Medical ResearchCancer specialists have taken a novel path to advance th
World medicine December 15,2023
How social media can help to understand treatment experiences of survivors of rare cancers

How social media can help to understand treatment experiences of survivors of rare cancers

byHudson Institute of Medical ResearchL–R: Associate Professor Simon Chu and Maria Alexiadis. Credit: Hudson Institute of Medical ResearchCancer specialists have taken a novel path to advance th
World medicine December 15,2023
Screening genes for the right treatment: New hope for children with cancer

Screening genes for the right treatment: New hope for children with cancer

by Children's Cancer Institute AustraliaGraphical Abstract. Credit:Cancer Research(2023). DOI: 10.1158/0008-5472.CAN-22-3702In a landmark study of 125 Australian children with high-ris
World medicine December 14,2023
Screening genes for the right treatment: New hope for children with cancer

Screening genes for the right treatment: New hope for children with cancer

by Children's Cancer Institute AustraliaGraphical Abstract. Credit:Cancer Research(2023). DOI: 10.1158/0008-5472.CAN-22-3702In a landmark study of 125 Australian children with high-ris
World medicine December 14,2023
Scan could guide use of drugs targeting a tumor's 'scaffold' to improve breast cancer treatment

Scan could guide use of drugs targeting a tumor's 'scaffold' to improve breast cancer treatment

byInstitute of Cancer ResearchImage: Normal breast epithelial cells with stained mitochondria (green), microtubules (red) and DNA (blue). Credit: Julia SeroResearchers have found a way to use a
World medicine December 14,2023
Scan could guide use of drugs targeting a tumor's 'scaffold' to improve breast cancer treatment

Scan could guide use of drugs targeting a tumor's 'scaffold' to improve breast cancer treatment

byInstitute of Cancer ResearchImage: Normal breast epithelial cells with stained mitochondria (green), microtubules (red) and DNA (blue). Credit: Julia SeroResearchers have found a way to use a
World medicine December 14,2023
Crosstalk between triple negative breast cancer and microenvironment

Crosstalk between triple negative breast cancer and microenvironment

by Impact Journals LLCActive pharmacological intervention trials in TNBC. Credit: 2023 Smrekar et al.A new review paper was published in the journalOncotargeton March 31, 2023, titled &quo
World medicine December 14,2023
Crosstalk between triple negative breast cancer and microenvironment

Crosstalk between triple negative breast cancer and microenvironment

by Impact Journals LLCActive pharmacological intervention trials in TNBC. Credit: 2023 Smrekar et al.A new review paper was published in the journalOncotargeton March 31, 2023, titled &quo
World medicine December 14,2023
Regorafenib, nivolumab, chemo combo found safe and effective for various cancers, heading to phase 3 trial

Regorafenib, nivolumab, chemo combo found safe and effective for various cancers, heading to phase 3 trial

by Justin Jackson , Medical XpressCredit: Pixabay/CC0 Public DomainResearchers at Memorial Sloan Kettering Cancer Center, New York, have concluded their phase 2 trial of chemotherapy in combination wi
World medicine December 14,2023
Regorafenib, nivolumab, chemo combo found safe and effective for various cancers, heading to phase 3 trial

Regorafenib, nivolumab, chemo combo found safe and effective for various cancers, heading to phase 3 trial

by Justin Jackson , Medical XpressCredit: Pixabay/CC0 Public DomainResearchers at Memorial Sloan Kettering Cancer Center, New York, have concluded their phase 2 trial of chemotherapy in combination wi
World medicine December 14,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com